Karlan BY - Search Results

1

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance.

Swisher EM, Sakai W, Karlan BY, Wurz K, Urban N, Taniguchi T. Swisher EM, et al. Among authors: karlan by. Cancer Res. 2008 Apr 15;68(8):2581-6. doi: 10.1158/0008-5472.CAN-08-0088. Cancer Res. 2008. PMID: 18413725 Free PMC article.

2

Glucocorticoid sensitivity of OVCA 433 human ovarian carcinoma cells: inhibition of plasminogen activators, cell growth, and morphological alterations.

Amin W, Karlan BY, Littlefield BA. Amin W, et al. Among authors: karlan by. Cancer Res. 1987 Nov 15;47(22):6040-5. Cancer Res. 1987. PMID: 3117361

3

Hormonal regulation of CA125 tumor marker expression in human ovarian carcinoma cells: inhibition by glucocorticoids.

Karlan BY, Amin W, Casper SE, Littlefield BA. Karlan BY, et al. Cancer Res. 1988 Jun 15;48(12):3502-6. Cancer Res. 1988. PMID: 3285997

4

Perioperative coagulopathy in patients undergoing primary cytoreduction.

Brown JV, Karlan BY, Greenspoon JS, Rosove MH, Lagasse LD. Brown JV, et al. Among authors: karlan by. Cancer. 1993 Apr 15;71(8):2557-61. doi: 10.1002/1097-0142(19930415)71:8<2557::aid-cncr2820710820>3.0.co;2-3. Cancer. 1993. PMID: 8453579

5

Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature.

Bristow RE, Lagasse LD, Karlan BY. Bristow RE, et al. Among authors: karlan by. Cancer. 1996 Nov 15;78(10):2049-62. Cancer. 1996. PMID: 8918397

6

Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma.

Bristow RE, Baldwin RL, Yamada SD, Korc M, Karlan BY. Bristow RE, et al. Among authors: karlan by. Cancer. 1999 Feb 1;85(3):658-68. doi: 10.1002/(sici)1097-0142(19990201)85:3<658::aid-cncr16>3.0.co;2-m. Cancer. 1999. PMID: 10091739

7

Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.

Schummer M, Ng WV, Bumgarner RE, Nelson PS, Schummer B, Bednarski DW, Hassell L, Baldwin RL, Karlan BY, Hood L. Schummer M, et al. Among authors: karlan by. Gene. 1999 Oct 1;238(2):375-85. doi: 10.1016/s0378-1119(99)00342-x. Gene. 1999. PMID: 10570965

8

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

9

Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.

Crump C, McIntosh MW, Urban N, Anderson G, Karlan BY. Crump C, et al. Among authors: karlan by. Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1107-11. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11045795

10

Genetic factors in ovarian carcinoma.

Li AJ, Karlan BY. Li AJ, et al. Among authors: karlan by. Curr Oncol Rep. 2001 Jan;3(1):27-32. doi: 10.1007/s11912-001-0039-y. Curr Oncol Rep. 2001. PMID: 11123866 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters